Clinical Trial – Adult ages 18-55 years with Attention Deficit Hyperactivity Disorder

Clinical Trial – Adult ages 18-55 years with Attention Deficit Hyperactivity Disorder

Attention Deficit – unable to pay attention, easily distracted

This Clinical Trial is looking for adults ages 18-55 with moderate to severe attention-deficit hyperactivity disorder (ADHD).

Patients must have

  1. Significant problems with inattention and/or hyperactivity/impulsivity.

Patients must not have

  1. Other significant medical or psychiatric disorders.
  2. Bipolar disorder, schizophrenia, or other psychotic disorder.
  3. Severe obesity (BMI greater than or equal to 39).
  4. Seizure disorder.
  5. Hypertension that is not controlled with treatment.
  6. Untreated thyroid disease.
  7. Tourette’s disorder or tics.
  8. Significant heart problems.
  9. Current use of any psychiatric medicines other than stimulants.
  10. Poor response in the past to amphetamines or methylphenidate taken in sufficient doses.
  11. Drug or alcohol abuse.
  12. Current use of street drugs with inability to stay off them.

The new medicine being used is a form of amphetamine.

See if you qualify. Please contact:

Call our office at 586-254-0707, or fill out a request for us to contact you.

Located in the Detroit metro area, Dr. Sangal of Sleep and Attention Disorders Institute sees patients from all over SE Michigan. Patients see him from communities like Warren, Shelby, Sterling Heights, Rochester Hills, Madison Heights, and Troy. Dr. Sangal is experienced in working with attention deficit disorders.

We treat every patient and clinical trial participant with respect, concern and consideration. To learn more about how you may participate in this study, please contact:

Sleep & Attention Disorders Institute

586-254-0707

44344 Dequindre Rd Suite 360

Sterling Heights, MI 48314

How should we best measure sleepiness?

How should we best measure sleepiness? There is no definite way of measuring sleepiness. In part, the problem is that there is no good definition of sleepiness. Secondly, we often confuse the trait of sleepiness with the state of sleepiness. It is like the story of the elephant and the blind men, with each expert…

Black box warning on sleeping pills

The FDA has a new black box warning on sleeping pills (zolpidem or AmbienR, eszopiclone or LunestaR, and zaleplon or SonataR). These can cause unusual behavior in sleep (parasomnias). Patients report walking in their sleep or eating in their sleep. This happens often enough. Rarely, patients may fall, are burned, or almost drown. They may…

Trazodone for sleep reduces worsening of memory

Trazodone for sleep reduces worsening of memory in patients with and without cognitive impairment. Trazodone has long been my preferred medicine for patients with chronic insomnia. I also use it frequently for sleep apnea patients who are not tolerating Continuous Positive Airway Pressure (CPAP) treatment. CPAP causes arousals and awakenings and disturbs sleep, and APAP…

Schedule An Appointment Today

44344 Dequindre Rd Suite 360
Sterling Heights, MI 48314
click here for directions